Nomad Power Solutions Files Merger Financials: $153.6M H1 Loss, Going Concern Doubt
NMAD sits 53% above its 52-week low of $2.36.
Summary
Nomad Power Solutions filed its amended 8-K with full merger financials, revealing a $153.6M H1 2026 net loss, a $148.6M warrant liability, going concern doubt, and only $170K in cash at June 30, 2026.
Key Events · M&A and Partnerships · NMAD
-
H1 2026 Net Loss of $153.6M
NOMAD Transportable Power Systems reported a net loss of $153.6 million for the six months ended June 30, 2026, driven primarily by a $148.6 million non-cash warrant liability charge related to 32.97 million pre-funded warrants issued to Aldersgate Capital Ltd. and BenEth Capital LLC on June 7, 2026.
-
Going Concern Doubt Confirmed
The auditor's report includes an explanatory paragraph on substantial doubt about NOMAD's ability to continue as a going concern. The company had only $170,000 in cash at June 30, 2026, a stockholders' deficit of $158.8 million, and estimates it needs to raise additional capital by December 31, 2026 to fund operations through 2027.
-
Pro Forma Combined Financials Disclosed
The pro forma combined entity shows total assets of $99.3 million, goodwill of $68.5 million, and a pro forma net loss of $9.0 million for H1 2026. Deemed consideration for the reverse acquisition was $118.3 million based on Lixte's closing price of $7.67 per share on July 1, 2026.
-
Warrant Liability Reclassified to Equity
The $148.6 million warrant liability was automatically exercised upon merger closing on July 1, 2026, with no additional consideration, and reclassified to additional paid-in capital. The associated non-recurring charges were eliminated from pro forma results.
Analysis · NMAD · Life Sciences
This amendment to the July 2 merger 8-K finally provides the audited and unaudited financial statements for NOMAD Transportable Power Systems, the pro forma combined financials, and the full business description and risk factors. The numbers are stark: NOMAD lost $153.6 million in the first half of 2026, driven almost entirely by a $148.6 million non-cash warrant liability charge tied to 32.97 million pre-funded warrants issued to Aldersgate Capital and BenEth Capital. The company has a stockholders' deficit of $158.8 million, only $170,000 in cash at June 30, 2026, and the auditor's report includes a going concern explanatory paragraph. The pro forma combined entity shows $99.3 million in total assets, $68.5 million in goodwill, and a $9.0 million pro forma net loss for H1 2026. The company estimates it needs to raise additional capital by December 31, 2026 to fund operations through 2027.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NMAD was trading at $3.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $58.1M. The 52-week trading range was $2.36 to $8.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.